Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in…
Arcus Biosciences, Inc. announced a clinical trial collaboration agreement with AstraZeneca to evaluate casdatifan (AB521), Arcus’s investigational HIF-2a inhibitor, in combination with…
Read More...
Read More...